Word

RILABNACEPT

Status

Pending

Status Code

686

Status Date

Tuesday, September 10, 2024

Serial Number

98348983

Mark Type

4

Filing Date

Tuesday, January 9, 2024

Published for Opposition

Tuesday, September 10, 2024

Trademark Owner History

Hangzhou Gene-based Biopharmaceutical Co., Ltd. - Owner At Publication

Classifications

5 Anti-inflammatory and antipyretic preparations; Anti-inflammatory preparations; Chemical reagents for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes

The wording Rilabnacept has no meaning in a foreign language.

Trademark Events

Jan 9, 2024

New Application Entered

Apr 28, 2024

New Application Office Supplied Data Entered

Aug 2, 2024

Assigned To Examiner

Aug 5, 2024

Approved For Pub - Principal Register

Aug 21, 2024

Notification Of Notice Of Publication E-Mailed

Sep 10, 2024

Published For Opposition

Sep 10, 2024

Official Gazette Publication Confirmation E-Mailed